NIAID Clinical Trial Studies Vitamin D3 in Pediatric Systemic Lupus Erythematosus
An NIAID-sponsored clinical trial is evaluating how vitamin D supplementation affects the immune function, blood sugar levels, and bone metabolism of children and adolescents who have systemic lupus erythematosus (SLE). People with SLE ages 5 to 20 may be eligible to participate in this study, which is being conducted at research institutions across the United States.
Did you know?
- The causes of SLE are unknown, but are believed to be linked to genetic, environmental, and hormonal factors.
- Females are affected by SLE far more than males.
- SLE disproportionately affects ethnic minority populations.